US protection ending in 2029: Chemically induced
As of the edition of 20 October 2026, 16 drugs have US protection that ends in 2029 in chemically induced; 11 of them have at least one company on route B because of it.
Sources: FDA Orange Book and Purple Book, other approval registers.
16 drugs
| Drug | US protection | Status | Holder | Target | Route B rows |
|---|---|---|---|---|---|
| Amifampridine | Ends 2029 (exclusivity) | Marketed | Angelini Pharma | 0 | |
| Atazanavir | Ends 2029 (patent) | Marketed | Bristol Myers Squibb | 0 | |
| Atezolizumab | Ends 2029 (orphan exclusivity) | Marketed | Roche | CD274 | 1 |
| Bendamustine | Ends 2029 (patent) | Marketed | Teva | 0 | |
| Budesonide | Ends 2029 (exclusivity) | Marketed | NR3C1 | 5 | |
| Cariprazine | Ends 2029 (patent) | Marketed | AbbVie | DRD2, DRD3 | 4 |
| Dapagliflozin | Ends 2029 (patent) | Marketed | AstraZeneca | SLC5A2 | 2 |
| Etonogestrel | Ends 2029 (exclusivity) | Marketed | Organon | PGR | 1 |
| Flurpiridaz | Ends 2029 (exclusivity) | Marketed | GE Healthcare | 0 | |
| Guselkumab | Ends 2029 (computed from the first US licence) | Marketed | Johnson & Johnson | IL23A | 1 |
| Lapatinib | Ends 2029 (patent) | Marketed | Novartis | EGFR | 2 |
| Linaclotide | Ends 2029 (exclusivity) | Marketed | AbbVie | GUCY2C | 3 |
| Phenobarbital | Ends 2029 (exclusivity) | Marketed | SUN Pharmaceutical Industries | 0 | |
| Suvorexant | Ends 2029 (patent) | Marketed | Merck & Co. | HCRTR1, HCRTR2 | 2 |
| Terlipressin | Ends 2029 (exclusivity) | Marketed | Byk-Mallinckrodt CIL | AVPR1A, AVPR1B, AVPR2 | 3 |
| Trazodone | Ends 2029 (patent) | Marketed | Pragma Pharmaceuticals | HTR2A, HTR2C | 1 |
Listed by name. A route B row is one company at one target; for a drug with one target that is the number of companies. US protection is the US only, and it is not the date generics or biosimilars can enter.
Which companies are on route B in 2029 in chemically induced
In the product11 of these 16 drugs have at least one company on route B. Which companies, and their scores, are in the product.
Get this list with the companies, scores and sources as a fileRequest access. Nothing is shown until you do.